TL;DR: The Centers for Medicare & Medicaid Services modified NCD 7 governing thermogenic therapy coverage policy, effective January 9, 2026. Medicare does not cover this service. Here's what billing teams need to know.
CMS updated NCD 7 — the National Coverage Determination governing thermogenic therapy under Medicare — with an effective date of January 9, 2026. Thermogenic therapy, the artificial induction of fever as a medical treatment, carries a blanket non-coverage determination under section 1862(a)(1) of the Social Security Act. The policy lists no applicable CPT or HCPCS codes. That absence itself is a signal worth understanding before a claim hits a Medicare Administrative Contractor.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Thermogenic Therapy |
| Policy Code | NCD 7 |
| Change Type | Modified |
| Effective Date | 2026-01-09 |
| Impact Level | Low — confirms existing non-coverage; no new billing exposure for most practices |
| Specialties Affected | Internal medicine, infectious disease, rheumatology, inpatient hospital billing |
| Key Action | Confirm no thermogenic therapy charges are entering your charge capture; flag inpatient stays where this service appeared alongside other covered services |
CMS Thermogenic Therapy Coverage Criteria and Medical Necessity Requirements 2026
The CMS thermogenic therapy coverage policy is straightforward: Medicare does not cover it. Full stop.
NCD 7 states that thermogenic therapy — regardless of the medium used to induce artificial fever — is not scientifically accepted for treating any specific disease. CMS cites section 1862(a)(1) of the Social Security Act, which requires that a service be reasonable and necessary for the treatment of an illness or injury. Thermogenic therapy does not meet that standard.
This is not a gray-zone medical necessity determination. CMS does not offer a pathway to coverage, not even with additional documentation or a prior authorization request. Prior authorization is irrelevant here — there is nothing to authorize.
The policy also addresses a nuance that matters for inpatient billing. If a patient is admitted to a hospital for legitimate, covered services, that inpatient stay remains billable even if thermogenic therapy was also provided during the stay. The covered inpatient services are not tainted by the presence of a non-covered service. Your reimbursement for those covered services stays intact. But the thermogenic therapy itself draws no separate payment.
CMS traces this determination back to the historical record. Thermogenic therapy has been in use since 1919, primarily for resistant infectious diseases, rheumatoid arthritis, and Sydenham's chorea. The arrival of effective antibiotics made the procedure largely obsolete as a treatment modality. The medical community moved on. This NCD reflects that.
CMS Thermogenic Therapy Exclusions and Non-Covered Indications
The exclusion here is total. CMS does not carve out any indication where thermogenic therapy qualifies for coverage.
The three historical use cases — resistant infectious diseases, rheumatoid arthritis, and Sydenham's chorea — are all explicitly subsumed under the non-coverage determination. The method of inducing fever does not change the outcome. Whether the fever is induced mechanically, pharmacologically, or by any other means, the claim denial result is the same.
There is no exception language in NCD 7. There is no "covered when medically necessary with documentation" clause. There is no local coverage determination pathway that overrides this national policy. This is a national, blanket exclusion, and no Medicare Administrative Contractor can reverse it at the local level.
Coverage Indications at a Glance
| Indication | Coverage Status | Relevant Codes | Notes |
|---|---|---|---|
| Resistant infectious diseases treated with thermogenic therapy | Not Covered | No codes listed in policy | CMS cites lack of scientific acceptance; replaced by antibiotics |
| Rheumatoid arthritis treated with thermogenic therapy | Not Covered | No codes listed in policy | Blanket exclusion under section 1862(a)(1) |
| Sydenham's chorea treated with thermogenic therapy | Not Covered | No codes listed in policy | Historical use; no current coverage pathway |
| Any other indication using artificial fever induction | Not Covered | No codes listed in policy | "Regardless of medium" — method of fever induction does not affect coverage status |
| Covered inpatient services provided during same stay | Covered (underlying stay) | Per applicable inpatient billing codes | Thermogenic therapy does not disqualify reimbursement for the inpatient stay itself |
CMS Thermogenic Therapy Billing Guidelines and Action Items 2026
This policy does not require a major operational overhaul. But it does require a few specific checks, especially if your practice or facility has any history of billing fever-induction therapies.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture before January 9, 2026. Search your charge master and superbills for any line items that could be coded as thermogenic or artificial fever therapy. If you find any, remove them or flag them for clinical review. This service has no reimbursement pathway under Medicare. |
| 2 | Review inpatient billing procedures for co-occurring services. If your facility ever documents thermogenic therapy in an inpatient record, train your coders to exclude it from billable charges while preserving the claim for legitimate covered services rendered during the same stay. The inpatient stay remains billable. The thermogenic therapy does not. |
| 3 | Do not submit claims expecting a denial to establish a record. Some billing teams use denial-then-appeal cycles to build coverage precedent. That approach does not apply here. NCD 7 is a national coverage determination — it overrides any local coverage determination or MAC-level discretion. An appeal will not change the outcome. |
| 4 | Check for any crossover in alternative or integrative medicine billing. If your practice offers services adjacent to fever therapy — hyperthermia treatment for cancer, for example — confirm those services are billed under their own correct CPT and HCPCS codes and clinical justification. Do not conflate oncologic hyperthermia with the thermogenic therapy defined under NCD 7. Different clinical context, different billing pathway. |
| 5 | Document the NCD reference in your internal billing guidelines. Add NCD 7 to your payer policy reference library with a note that it carries a blanket non-coverage determination effective January 9, 2026. This protects your team if a provider ever asks why a charge was removed. |
If you work in a setting that has used fever-induction therapies in any form — including as part of research protocols or integrative treatment plans — talk to your compliance officer before the effective date. The line between thermogenic therapy under NCD 7 and other heat-based or fever-inducing modalities can get blurry in documentation. Blurry documentation creates claim denial risk and potentially audit exposure.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Thermogenic Therapy Under NCD 7
The thermogenic therapy billing picture here is simple, and not in a good way.
Covered CPT Codes
There are no covered CPT or HCPCS codes under NCD 7. CMS lists no applicable codes for this service.
Not Covered / Non-Covered Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| No codes listed | — | CMS does not enumerate specific codes for thermogenic therapy | Blanket non-coverage determination under NCD 7; not reasonable and necessary per section 1862(a)(1) |
Key ICD-10-CM Diagnosis Codes
No ICD-10-CM codes are listed in the policy data. CMS does not specify diagnosis codes that would trigger or support this service, because no coverage pathway exists under which a diagnosis code would matter.
The absence of codes in this policy is itself a billing signal. When CMS declines to enumerate CPT, HCPCS, or ICD-10 codes for a service, it typically means the agency does not expect the service to appear on claims at all. If you encounter a charge that has no clear code mapping and resembles artificial fever induction, treat it as a red flag and escalate to your medical director before billing.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.